Xconomy National

Archives

by in

Entry	Author	Date	Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010	Gregory T. Huang	12/27/10	Boston
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News	Erin Kutz	12/03/10	Boston
Glaxo Ends Resveratrol Drug Study	Ryan McBride	12/01/10	Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News	Erin Kutz	08/20/10	Boston
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online	Ryan McBride	08/12/10	Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News	Erin Kutz	05/07/10	Boston
Glaxo Stops Study of Sirtris “Red Wine” Drug in Cancer Patients	Ryan McBride	05/05/10	Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News	Ryan McBride	09/30/09	Boston
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs	Ryan McBride	10/23/08	Boston
Sirtris’ Westphal Enjoying Life Under GSK Ownership; Hints at Positive Human Data on Next-Gen Drugs to Extend Healthy Life (and Still Partying on Fridays)	Ryan McBride	09/18/08	Boston
Barbara Walters to Feature Sirtris	Wade Roush	03/31/08	Boston
Sirtris Returns to Its “Roots” in Crop Deal with Bayer	Wade Roush	03/12/08	Boston
Sirtris Finds Anti-Cancer Effect, Teams with NIH	Wade Roush	02/22/08	Boston
Sirtris Anti-Aging Drug Generates Buzz, But May Already Be Old News	Wade Roush	01/08/08	Boston
Page 1 of 1